Back to search
FDAFDA · Food and drugs·Recall number D-0383-2026

Midodrine Hydrochloride Tablets, USP, 5 mg, 50 Tablets (5 x 10 blister packs), Rx only, Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 46268 USA, NDC 0904-6818-06.

Published March 11, 2026 · Recall initiated: February 17, 2026

Summary

FDA records drug Class II recall D-0383-2026, published March 11, 2026 and initiated February 17, 2026. Recalling firm: The Harvard Drug Group LLC; Status: Ongoing; Reported quantity: 8892 cartons; Lot: Lot # N02640, Exp Date: 08/2027. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Defective container; inadequately sealed blister packaging.

What to do

Voluntary: Firm initiated · Letter

Get an email if MIDODRINE HYDROCHLORIDE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
MIDODRINE HYDROCHLORIDE
Manufacturer
The Harvard Drug Group LLC
Distributor
Nationwide US.
Lot
Lot # N02640, Exp Date: 08/2027
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Midodrine Hydrochloride Tablets, USP, 5 mg, 50 Tablets (5 x 10 blister packs), Rx only, Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 46268 USA, NDC 0904-6818-06. recalled?

Yes. FDA published recall D-0383-2026 on March 11, 2026. Reported hazard: Defective container; inadequately sealed blister packaging.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: MIDODRINE HYDROCHLORIDE.